Contact
William H. Frishman, M.D., is a practicing internist and cardiologist with a research interest in cardiovascular pharmacology, clinical epidemiology and geriatrics. Dr. Frishman has authored and co-authored more than 900 original articles, reviews and book chapters. He has also edited, co-edited, authored and co-authored twelve full-length textbooks, including a major text, Cardiovascular Pharmacotherapeutics (McGraw-Hill) now in its second edition. Dr. Frishman published three books: Complementary and Integrative Therapies for Cardiovascular Disease (Elsevier 2005), Cardiovascular Regeneration and Stem Cell Therapy (Blackwell Futura, 2007), and Hypertension: A Clinical Guide (Lippincott, 2007). He is also the supplements editor for the American Journal of Medicine and a co-editor of the journal Cardiology in Review and the Yearbook of Medicine.
Education
- M.D., Boston University School of Medicine
Areas of Expertise
- Cardiovascular pharmacology
- Clinical epidemiology
- Geriatrics
Honors and Awards
- Teaching Scholar Award of the American Heart Association
- Preventative Cardiology Academic Award from the National Heart, Lung and Blood Institute
- Distinguished Teacher Award, Alpha Omega Alpha National Medical Honor Society
Research
Dr. Frishman has served as a principal investigator in multiple NIH funded studies including the "Systolic Hypertension in the Elderly" (SHEP) Trial, the "Studies of Left Ventricular Dysfunction" (SOLVD), the "Womens Health Initiative Trial" (WHI) and the "Bronx Longitudinal Aging Study."
Publications
- Zhang H, Maksymiuk V, Frishman WH, et. al. "Potential Therapeutic Benefits of Glucagon-Like-Peptide-1 Agonists and Atrial Fibrillation." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001003
- Tran HH, Thu A, Twayana AR, et. al. "Targeting Corin and Furin in Hypertension and Heart Failure: A New Therapeutic Frontier in Cardiovascular Therapeutics." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000000999
- Tran HH, Thu A, Twayana AR, et. al. "Coronary Sinus Reducer in Refractory Angina: A Targeted Approach to Microvascular Ischemia and Symptom Relief." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001001
- Tran HH, Thu A, Twayana AR, et. al. "Orally Inhaled Flecainide for Paroxysmal Atrial Fibrillation: Emerging Evidence and Therapeutic Potential in Cardioversion to Sinus Rhythm." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000001000
- Charlat M, Poltiyelova E, Silverman J, et. al. "Hypercholesterolemia of Cholestasis." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000000994
- Raizada A, Parikh MA, Frishman WH, et. al. "The Significance of Premature Atrial Contractions in the Normal Heart." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000000986
- Thapa S, Shah S, Bhattarai M, et. al. "Efficacy and Safety of Mechanical Thrombectomy in Acute Ischemic Stroke Secondary to Infective Endocarditis: A Systematic Review and Meta-Analysis." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000000996
